Healthcare in Saudi Arabia / NEOM
AI in Saudi Arabia / NEOM pharmaceutical operations — drug discovery, manufacturing quality, clinical trial analysis — operates under FDA AI/ML guidance, GxP validation requirements, and UAE PDPL and DIFC compliance frameworks. Clinical AI that cannot demonstrate validation and audit trail compliance will not survive FDA review.
Pharmaceutical technology lives under FDA 21 CFR Part 11. Data integrity isn't optional — it's existential. Clinical trial data, manufacturing execution, regulatory submissions — every system requires validated, compliant infrastructure.
How We Deliver in Saudi Arabia / NEOM
UAE & Gulf and Healthcare Frameworks
Healthcare organizations in Saudi Arabia / NEOM operate under both UAE & Gulf regional frameworks and sector-specific compliance requirements. We embed all applicable frameworks architecturally — not as a parallel compliance workstream running alongside engineering.